A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Clinical trial NCT05429593 · COMPLETED
Trial details
- NCT number
- NCT05429593
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2023-03-10
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.